Email this article New opportunities for complex treatment of oropharyngeal candidiasis in HIV-infected patients in the later stages of the disease
- Authors: Charushin A.O.1, Elovikov A.M.1, Charushina I.P.1
-
Affiliations:
- Wagner Perm State Medical University
- Issue: Vol 95, No 1 (2023)
- Pages: 52-56
- Section: Original articles
- URL: https://journal-vniispk.ru/0040-3660/article/view/133010
- DOI: https://doi.org/10.26442/00403660.2023.01.202064
- ID: 133010
Cite item
Full Text
Abstract
Treatment of recurrent oropharyngeal candidiasis (OPC) in HIV-infected patients is a serious clinical problem due to the emergence of resistant Candida strains, the risk of invasive disease, and high economic costs, which warrants the need for new treatment regimens.
Aim. To improve the treatment regimen of OPC in the later stages of HIV infection by combining the complex herbal medicinal product Tonsilgon® N with fluconazole and evaluate the effectiveness of this combination.
Materials and methods. A comparative randomized clinical study included 65 patients divided into observation and comparison groups, receiving fluconazole plus Tonsilgon® H and fluconazole monotherapy, respectively, for 7 days. On days 1 and 8, the severity of OPC clinical signs was assessed using a visual analog scale. The secretory immunoglobulin A in saliva was measured as a criterion for changing the level of local mucosal protection of the oral cavity and pharynx.
Conclusion. This treatment regimen for oropharyngeal candidiasis in patients with HIV infection in the later stages of the disease (IVB–IVC) with fluconazole and Tonsilgon® N is effective, which is confirmed by a significantly more pronounced regression of clinical signs (pM–U<0.01), as well as an increase in the level of secretory immunoglobulin A in the oral fluid (from 0.62±0.33 g/L to 0.81±0.18 g/L; p<0.05).
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Artem O. Charushin
Wagner Perm State Medical University
Author for correspondence.
Email: art-charushin@yandex.ru
ORCID iD: 0000-0001-9504-4046
канд. мед. наук, доц. каф. оториноларингологии
Russian Federation, PermAleksey M. Elovikov
Wagner Perm State Medical University
Email: art-charushin@yandex.ru
д-р мед. наук, доц., зав. каф. оториноларингологии
Russian Federation, PermIrina P. Charushina
Wagner Perm State Medical University
Email: art-charushin@yandex.ru
д-р мед. наук, доц. каф. инфекционных болезней
Russian Federation, PermReferences
- Дрынов Г.И., Иванюшина О.К., Дьякова Ф.Н. Препарат Тонзилгон Н в лечении хронического тонзиллита у детей. Эффективная фармакотерапия. 2014;59(3):4-6 [Drynov GI, Ivanyushina OK, Dyakova FN. Tonsilgon® N in Therapy of Chronic Tonsillitis in Children. Effective Pharmacotherapy. 2014;59(3):4-6 (in Russian)].
- Смирнова Г.И. Опыт применения Синупрета и Тонзилгона Н для профилактики и лечения острых респираторных заболеваний у часто болеющих детей. Детский доктор. 2001;4:25-9 [Smirnova GI. Experience of use of Sinupret and Tonsilgon N in prophylaxis and treatment of frequent acute respiratory diseases in children. Detskii doctor. 2001;4:25-9 (in Russian)].
- Хабаров А.С., Барышева Г.Н., Бахарева И.В., и др. Иммунореабилитация фитопрепаратом «Тонзилгон Н» лиц, находившихся в экологически неблагоприятном районе. Российская ринология. 2014;22(1):26-31 [Khabarov AS, Barysheva GN, Bakhareva IV, et al. Tonzilgon N immunorehabilitation of people, who lived in ecologically unfavorable areas. Russian Rhinology. 2014;22(1):26-31 (in Russian)].
- Коваленко Л.П., Шипаева Е.В, Кольченко И.И. Иммунокоррегирующие свойства фитопрепарата Тонзилгон Н. РМЖ. 2008;16(25):1684-7 [Kovalenko LP, Shipayeva EV, Kolchenko II. Immunocorrecting Properties of Tonsilgon N Phytoparate. RMJ. 2008;16(25):1684-7 (in Russian)].
- Тарасова Г.Д., Мирзабекян Е.В., Кириченко И.М. Значение фитотерапии в лечении острого тонзиллофарингита нестрептококкового генеза. Вестник оториноларингологии. 2020;85(5):65-70 [Tarasova GD, Mirzabekyan EV, Kirichenko IM. The value of herbal medicine in the treatment of acute tonsillopharyngitis of non-streptococcal genesis. Vestnik Oto-Rino-Laringologii. 2020;85(5):65-70 (in Russian)].
- Крюков А.И., Кунельская В.Я., Шадрин Г.Б. Микотические поражения ЛОР органов. Лечебное дело. 2011;3:10-6 [Kryukov AI, Kunelskaya VYa, Shadrin GB. Mycotic Damage in Otorhinolaryngology. Lechebnoe delo. 2011;3:10-6 (in Russian)].
- Шабашова Н.В. Особенности локального иммунного ответа и его дефекты при орофарингеальном кандидозе (обзор). Проблемы медицинской микологии. 2010;12(4):3-9 [Shabashova NВ. Peculiarities of the local immune answer and its defects at oropharyngeal candidоsis (review). Problems in medical mycology. 2010;12(4):3-9 (in Russian)].
Supplementary files
